Jeffrey Hung
Stock Analyst at Morgan Stanley
Total Price Targets
17
Stocks Covered
11
Sectors
Healthcare
Most Recent
Dec 29, 2025
Notable Calls (Last 12 Months)
Stocks Covered by Jeffrey Hung
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc. | $55.00 | $24.79 | +121.9% | 1 | Dec 29, 2025 |
| BIOA | BioAge Labs, Inc. | $40.00 | $16.82 | +137.9% | 1 | Oct 21, 2024 |
| EXEL | Exelixis, Inc. | $30.00 | $43.81 | -31.5% | 3 | Oct 15, 2024 |
| PTCT | PTC Therapeutics, Inc. | $45.00 | $65.06 | -30.8% | 3 | Oct 11, 2024 |
| CGEM | Cullinan Therapeutics, Inc. | $38.00 | $13.48 | +181.8% | 1 | Aug 8, 2024 |
| ACAD | ACADIA Pharmaceuticals Inc. | $20.00 | $21.95 | -8.9% | 1 | Aug 7, 2024 |
| NBIX | Neurocrine Biosciences, Inc. | $170.00 | $131.64 | +29.1% | 1 | Jul 12, 2024 |
| INSM | Insmed Incorporated | $60.00 | $133.75 | -55.1% | 2 | May 28, 2024 |
| CRNX | Crinetics Pharmaceuticals, Inc. | $70.00 | $38.93 | +79.8% | 1 | May 22, 2024 |
| FOLD | Amicus Therapeutics, Inc. | $19.00 | $14.49 | +31.1% | 2 | May 9, 2024 |
| CYTK | Cytokinetics, Incorporated | $45.00 | $64.40 | -30.1% | 1 | Oct 8, 2021 |
Recent Activity
- Dec 29, 2025— Set$55.00price target onRARE(Ultragenyx Pharmaceutical Inc.)
- Oct 21, 2024— Set$40.00price target onBIOA(BioAge Labs, Inc.)
- Oct 15, 2024— Set$30.00price target onEXEL(Exelixis, Inc.)
- Oct 11, 2024— Set$28.00price target onEXEL(Exelixis, Inc.)
- Oct 11, 2024— Set$45.00price target onPTCT(PTC Therapeutics, Inc.)
- Aug 8, 2024— Set$38.00price target onCGEM(Cullinan Therapeutics, Inc.)
- Aug 7, 2024— Set$20.00price target onACAD(ACADIA Pharmaceuticals Inc.)
- Jul 12, 2024— Set$32.00price target onPTCT(PTC Therapeutics, Inc.)
- Jul 12, 2024— Set$170.00price target onNBIX(Neurocrine Biosciences, Inc.)
- May 28, 2024— Set$60.00price target onINSM(Insmed Incorporated)
- May 22, 2024— Set$70.00price target onCRNX(Crinetics Pharmaceuticals, Inc.)
- May 9, 2024— Set$43.00price target onINSM(Insmed Incorporated)
- May 9, 2024— Set$19.00price target onFOLD(Amicus Therapeutics, Inc.)
- Apr 26, 2024— Set$30.00price target onPTCT(PTC Therapeutics, Inc.)
- Dec 19, 2023— Set$20.00price target onFOLD(Amicus Therapeutics, Inc.)
- Oct 8, 2021— Set$45.00price target onCYTK(Cytokinetics, Incorporated)
- Apr 19, 2021— Set$26.00price target onEXEL(Exelixis, Inc.)
Frequently Asked Questions
Who is Jeffrey Hung?
Jeffrey Hung is a stock analyst at Morgan Stanley covering 11 stocks primarily in Healthcare. They have issued 17 price targets since Apr 19, 2021.
What stocks does Jeffrey Hung cover?
Jeffrey Hung currently covers 11 stocks, including EXEL, PTCT, INSM, FOLD, RARE.
What is Jeffrey Hung's latest price target?
Jeffrey Hung's most recent price target was $55.00 on RARE (Ultragenyx Pharmaceutical Inc.), set on Dec 29, 2025.
What is Jeffrey Hung's highest price target?
Jeffrey Hung's highest issued price target is $170.00 on NBIX, set on Jul 12, 2024.
More Analysts at Morgan Stanley
Coverage based on publicly published price targets. Not investment advice.